Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of April 2025. The report specifically details a transaction in own shares executed under the Company's share buyback programme announced on March 28, 2025.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on share repurchase activity.
- Shares Purchased: 894,401 ordinary shares
- Purchase Date: April 28, 2025
- Highest Price Paid: 380.00 pence per share
- Lowest Price Paid: 376.20 pence per share
- Volume Weighted Average Price: 377.81 pence per share
- Post-Transaction Registered Capital: 9,022,705,735 ordinary shares
- Treasury Shares Held: 4,080,205
- Voting Shares Outstanding: 9,018,625,530
Material Changes
The primary material change is the reduction of outstanding voting shares due to the cancellation of 894,401 shares purchased for cancellation. The filing does not disclose changes in operational performance or financial position compared to prior periods.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future performance, or discussion of risks and contingencies. It serves as a regulatory disclosure of a completed share transaction in compliance with the Market Abuse Regulation.
Key Facts for Investor Verification
- Verify the total number of shares purchased under the buyback programme to date against the March 28, 2025 announcement.
- Confirm the current number of voting shares (9,018,625,530) for disclosure threshold calculations under FCA rules.
- Review the full trade breakdown available via the provided London Stock Exchange link for granular transaction data.
- Note that this filing does not contain financial results; refer to the most recent Form 20-F or quarterly earnings release for operational metrics.